Fig. 2
From: Visualizing adverse events in clinical trials using correspondence analysis with R-package visae
Asymmetric contribution biplots for AE at cycle 1 from B35 trial – a AE class defined by AE grades; b AE class defined by AE domains with contribution at least 5.0%; c AE class defined by AE domains and grades with contribution and relative frequency at least 1.64%; d AE class defined by AE terms with contribution at least 0.94% and relative frequency at least 0.47%; e AE class defined by AE terms and grades with contribution and relative frequency at least 0.52%